Market open

Treace Medical Concepts/$TMCI

14:30
22:10
05:45
13:25
21:00
1D1W1MYTD1Y5YMAX

About Treace Medical Concepts

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Ticker

$TMCI
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
Ponte Vedra, United States

Employees

516
Website
www.treace.com

TMCI Metrics

BasicAdvanced
$499M
-
-$0.99
0.24
-

$499M

0.24

$15.98

$3.92

277K

4.119

2.811

66.458

66.842

-11.84%

-17.13%

-50.69%

2.446

4.75

5.95

-11.489

16.14%

23.58%

33.59%

55.31%

What the Analysts think about TMCI

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Treace Medical Concepts stock.

TMCI Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

TMCI Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

TMCI News

AllArticlesVideos
Shareholder Rights Advocates at Levi & Korsinsky Investigate Treace Medical Concepts, Inc. (TMCI) Regarding Possible Securities Fraud Violations

Shareholder Rights Advocates at Levi & Korsinsky Investigate Treace Medical Concepts, Inc. (TMCI) Regarding Possible Securities Fraud Violations

Accesswire·20 hours ago
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud

Accesswire·21 hours ago
An Investigation Has Commenced on Behalf of Treace Medical Concepts, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TMCI Losses

An Investigation Has Commenced on Behalf of Treace Medical Concepts, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TMCI Losses

Accesswire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TMCI

$

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Treace Medical Concepts stock?

Treace Medical Concepts (TMCI) has a market cap of $499M as of January 15, 2025.

What is the P/E ratio for Treace Medical Concepts stock?

The price to earnings (P/E) ratio for Treace Medical Concepts (TMCI) stock is 0 as of January 15, 2025.

Does Treace Medical Concepts stock pay dividends?

No, Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Treace Medical Concepts dividend payment date?

Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders.

What is the beta indicator for Treace Medical Concepts?

Treace Medical Concepts (TMCI) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.